Skip to main content
. 2020 Jun 19;63(4):514–520. doi: 10.5468/ogs.19170

Table 2.

Outcome variables in 2 groups and predict of variables by logistic regression

Variables INH (n=86) Misoprostol (n=90) P-value OR (95% CI) (misoprostol/INH)
Primary outcomes
 Hysteroscopy entrance
  Yes 67 (77.9) 45 (50.0) 1.000 1.00
  No 19 (22.1) 45 (50.0) 0.0001 0.57 (0.43–0.75)
Secondary outcomes
 Non responses
  Yes 19 (22.1) 45 (50.0) 1.000 1.00
  No 67 (77.9) 45 (50.0) 0.0001 1.75 (1.32–2.30)
 Intra uterine pathology
  Normal 19 (22.1) 12 (13.3) - 1.00
  Polyp 31 (36.0) 42 (46.7) 0.090 0.71 (0.26–1.95)
  Myoma 17 (19.8) 15 (16.7) 0.513 0.75 (0.56–0.99)
  Asherman’s syndrome 0 (0) 4 (4.4) 0.035 0.94 (0.22–0.99)
  Septum 6 (7.0) 4 (4.4) 0.612 0.63 (0.07–5.10)
  Atrophy 2 (2.0) 2 (2.2) 0.530 0.90 (0.27–3.01)
  Focal hyperplasia 10 (11.6) 7 (7.8) 0.554 1.05 (0.95–1.16)
  Product of conception 1 (1.2) 4 (4.4) 0.035 0.75 (0.56–0.99)
  Max Hegar size in nonresponses 3.73±1.28 3.84±1.04 0.726 -

Values are presented as number (%) or mean±standard deviation.

CI, confidence interval; OR, odds ratio; INH, isonicotinic acid hydrazide.